Pediatrix Medical Group, Inc. announced that Mark S. Ordan, who has been named executive chair of the Company's board of directors and has served as chief executive officer since July 2020. Guy P. Sansone, who previously served as chair of the Company's board of directors since July 2020, has been named lead independent director. Each of these transitions will go into effect at the end of the year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.22 USD | +0.61% | -11.90% | -11.61% |
May. 07 | Transcript : Pediatrix Medical Group, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q1 Revenue $495.1M, vs. Street Est of $500.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.61% | 681M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.23% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- MD Stock
- News Pediatrix Medical Group, Inc.
- Pediatrix Medical Group, Inc. Announces Executive Changes